1. Cerebral Ischemia-Reperfusion Injury: Lysophosphatidic Acid Mediates Inflammation by Decreasing the Expression of Liver X Receptor
- Author
-
Yan-dong Shan, Zhi-xiu Luo, Jie Zhou, Yang Zhu, Xiao-yun Zeng, Guilin Yan, Chao Wang, Yahang Lin, and Junyi Wu
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Blepharospasm ,Interleukin-1beta ,Ischemia ,Rats, Sprague-Dawley ,Pathogenesis ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,Lysophosphatidic acid ,medicine ,Animals ,Liver X receptor ,TUNEL assay ,Interleukin-6 ,Tumor Necrosis Factor-alpha ,business.industry ,NF-kappa B ,Brain ,Infarction, Middle Cerebral Artery ,General Medicine ,medicine.disease ,Rats ,030104 developmental biology ,Endocrinology ,chemistry ,Terminal deoxynucleotidyl transferase ,lipids (amino acids, peptides, and proteins) ,Lysophospholipids ,Signal transduction ,business ,Reperfusion injury ,030217 neurology & neurosurgery - Abstract
Lysophosphatidic acid (LPA), a ubiquitous phospholipid, plays a crucial role in the pathogenesis and pathophysiological process of neurological diseases, which constitute the pathological course after cerebral ischemia. Nevertheless, the molecular mechanisms associated with the pathogenic roles of LPA remain elusive. In this study, we evaluated the expression of the liver X receptor (LXR) and nuclear factor kappa B (NFκB) by Western blotting, quantified the levels of IL-1β, IL-6, TNF-α, and LPA by ELISA, and evaluated apoptosis and infarct by TUNEL (terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling) and TTC (triphenyltetrazolium chloride) staining respectively in Sprague-Dawley (SD) rats after middle cerebral artery occlusion (MCAO). The levels of LPA, an extracellular signaling molecule, increased after ischemia and caused neurological injury effect, decreased the expression level of LXR, and increased the expression level of inflammatory factors (IL-1β, IL-6, and TNF-α) via the NFκB signaling pathway. This elevated LPA-induced pathological process is one of the pathological reactions associated with ischemic brain injury. We present a direct or indirect connection between LPA and LXR in the pathophysiological process. In conclusion, we speculate that the inhibition of LPA generation and administration of LXR agonist may be explored as potential cerebral infarction treatment strategies.
- Published
- 2020
- Full Text
- View/download PDF